The Playground

    Quote from JedRothwell

    Why are you trying to kill people? 800,000 dead Americans is not enough for you?

    More from Jed's Disney land. 800'000 US citizen have been killed by the US FM&R/B mafia by treating them with fake science based - non working drugs. The mafia actively undermined all working drugs.


    This is the largest killing (Exceeding 9/11 Perl harbor) of US folks the FM mafia ever did organize. It's all documented and I hope some folks like Fauci will get a death sentence.


    Only an idiot takes a CoV-19 gene therapy if he has a cure at his hands!


    Post edited.

    Quote from Zephir_AWT

    Researchers estimate the growth and immune escape of the Omicron variant in England. They used data from the UKHSA and NHS for all PCR-confirmed SARS-CoV-2 cases in England who had taken a COVID test between November 29th and December 11th 2021

    The new report (Report 49) from the Imperial College London COVID-19 response team estimates that the risk of reinfection with the Omicron variant is 5.4 times greater than that of the Delta variant. This implies that the protection against reinfection by Omicron afforded by past infection may be as low as 19%. Vaccine effectiveness estimates against symptomatic Omicron infection of between 0% and 20% after two doses. See also: ‘Report 49 - Growth, population distribution and immune escape of Omicron in England’

    That is better Zephir!


    All true - although as with anything about omicron what you can conclude from it is still a bit uncertain.


    It is why the UK has this big push (mostly successful) to get everyone booster vaccinated.


    Data posted helpfully RobertBryant:

    Quote from RobertBryant

    Danish Omicron vs Delta ..unvaccinated and booster cf vaccinated w/o booster.

    In Dk the booster is either Moderna of Pfizer

    https://www.medrxiv.org/conten…12.27.21268278v1.full.pdf

    https://www.sst.dk/en/English/…ID-19-vaccines-in-Denmark

    Shows booster vaccination pretty good at reducing infection and transmission against even omicron - though obviously it is relatively much worse than for delta.


    The other part of the picture is that efficacy against infection from delta is known is much worse than efficacy against serious disease and death - which does not wane over a few months in the same way. We are not SURE how it goes with omicron, but initial signs look pretty good.


    THH

    Quote from zorud

    The immunity after an infection lasts "live long"”

    It's in quotation marks. But trolls seem not able to grasp the difference. Immunity from SARS lasted > 10 years. Reinfection so far never did cause a death (confirmed by US CDC). So per CoV-19 gene therapy (clown) definition the new immunity potentially lasts live long...

    More word salad, read previous posts,

    Quote from Wyttenbach

    It's in quotation marks. But trolls seem not able to grasp the difference. Immunity from SARS lasted > 10 years. Reinfection so far never did cause a death (confirmed by US CDC). So per CoV-19 gene therapy (clown) definition the new immunity potentially lasts live long...

    So: let us suppose the things you say here are all true (big assumption!).


    The conclusions you draw are wrong. You are changing the goalposts and now defining immunity to be efficacy against death. And, further, extrapolating from 2 years max (1 year typical) to 10 years.


    Your comment about SARS is irrelevant. We have no idea how long real-world immunity against SARS lasts, because SARS is not endemic in the population. All we know is that antibodies can be found - which is a different thing. But in any case SARS and SARS-COV-2 are very different.


    In terms of mixing up different definitions in one argument you go as far as is humanly possible:


    On the one hand you take a theoretical "can we see antibodies" definition of SARS immunity.

    On the other hand you take a "has anyone died after 1 year typical" definition of SARS-CoV-2 immunity and than extrapolate from 1 year typical to 10 years.


    Oh - at end of this post I did a 10s google-W-fact-check. Guess what I found :)


    First Omicron Death In U.S.: Reinfection In Unvaccinated Man Who Previously Had Covid-19
    This raises questions as to how well "natural immunity" from a previous SARS-CoV-2 infection might protect against the Omicron variant
    www.forbes.com

    A little perspective


    According to a Harris County Public Health (HCPH) report the man was between 50 and 60 years of age. He had underlying health conditions that put him at higher risk for severe Covid-19.

    Quote from zorud

    Interesting report from Texas…

    I never read such "interesting" FUD from USA. I look at real data and these say in UK and CH vaccines give you at best a 60% protection from death. This is overall!


    But with clever sub-grouping you can prove everything up to 100% protection as e.g in CH we had no deaths age<30 since "vaccination" did start. But of course we had vaccine deaths in this group including children... So we have -minus infinite protection among gene therapy people age < 30 ?!


    So fairy tales don't help. Age 50 rarely dies. You need > 100'000 gene therapy treated people to save one death in this group...

    Quote from Wyttenbach

    I never read such "interesting" FUD from USA. I look at real data and these say in UK and CH vaccines give you at best a 60% protection from death. This is overall!


    But with clever sub-grouping you can prove everything up to 100% protection as e.g in CH we had no deaths age<30 since "vaccination" did start. But of course we had vaccine deaths in this group including children... So we have -minus infinite protection among gene therapy people age < 30 ?!


    So fairy tales don't help. Age 50 rarely dies. You need > 100'000 gene therapy treated people to save one death in this group...

    So let’s look at the real data from UK you prefer… 😊

    “Unvaccinated people were more likely to be reinfected

    • The rate of reinfections was low in the UK between 2 July 2020 and 1 December 2021.
    • People who received a second vaccine dose over 90 days ago were more likely to be reinfected than those who received it 14 to 89 days ago.
    • Unvaccinated people were three times more likely to be reinfected than those who had their second vaccine 14 to 89 days ago.
    • People were more likely to be reinfected if they had a lower viral load at their initial infection.
    • The risk of reinfection was higher when the Delta variant of COVID-19 was the dominant strain (from 17 May 2021) than when the Alpha variant was dominant.
    • Because of the time period contributing to this analysis, Omicron infections will not be impacting these estimates. “


    Coronavirus (COVID-19) latest insights - Office for National Statistics

    Thailand Pays out its First 8,470 COVID-19 Vaccine Injury Claims under National Health Security Office Program


    Thailand Pays out its First 8,470 COVID-19 Vaccine Injury Claims under National Health Security Office Program
    The government of Thailand is committing approximately $30 billion to compensate individuals who have experienced adverse side events from the COVID-19
    trialsitenews.com


    The government of Thailand is committing approximately $30 billion to compensate individuals who have experienced adverse side events from the COVID-19 vaccines over the past several months, reports the Southeast nation’s National Health Security Office (NHSO). To date 8,470 claimants, out of a total of 11,707 have been compensated reports Atthaporn Limpanyalet, deputy secretary-general of the NHSO.


    Thus far, about 65.1% of the country’s population is fully vaccinated and nearly 9% of the population has received a third booster dose. Thailand experienced a huge surge in Delta variant-driven infections over the summer but new cases have rapidly decreased in number. To put in perspective, by August 15, the country reported 21,282 new cases; on December 30 that number arrived at 3,037. Record numbers of deaths for this Southeast Asian country hovered over 250 fatalities per day during August and parts of September but deaths have dramatically declined down to 25 nationwide yesterday.


    Categories for Claims

    The NHSO segments COVID-19 vaccine injury claims into three categories including:


    Mild-to-moderate side effects

    Temporary paralysis and/or loss of other bodily functions

    Permanent paralysis or death

    Multiple Thai media including the prominent Bangkok Post reports that for each category a corresponding amount is allocated as follows:


    COVID Vaccine Injury Category #s Baht/USD

    Mild-to-moderate side effects 6,298 100,000 $3,010US

    Temporary paralysis and/or loss of other bodily functions 210 240,000 $7,224US

    Permanent paralysis or death 1,962 400,000 $12,040

    Note, a claimant can seek compensation for themselves or relatives. The Bangkok Post reports that 1,752 of the claims have been rejected due to the failure of the claimant to meet the adverse event criteria above. Thus far 615 Thais have appealed this rejection.


    The NHSO’s Atthaporn reports that 13 committees are dispersed across the country to process claims which are apparently remunerated within five days of NHSO authorization.


    Vaccine Background Thailand

    TrialSite reported on early delays in vaccine production in Thailand, as a questionable contract was allocated to a biotech company owned by the nation’s King Vajiralongkorn. His biotech firm called Siam Bioscience received a technology transfer as part of a co-investment deal to produce the vaccine.


    The aforementioned deal was based on the nation’s order of 26 million doses of the AstraZeneca (Oxford) COVID-19 vaccine by November 2020 as reported in various media. The government ordered another 35 million additional doses of AZD1222 by January 2021. While the nation’s government discussed an additional purchase of 61 million AZD1222 doses, a leaked document cast doubt on this as it evidenced AstraZeneca would only deliver 60% of the total amount.


    Additional vaccine products were accessed, including 2 million doses from China’s Sinovac—apparently, the Thai conglomerate called Charoen Pokphand invested in Sinovac by April 2021.


    The Thai government also procured 30 million of the mRNA-based vaccine from Pfizer-BioNTech, yet only 3.5 million doses have arrived. Part of the supply of the BNT162b2 vaccine came as donations from the American government. An additional 5 million doses of the single-shot Janssen (Johnson and Johnson) vaccine were ordered.


    The Thai government also has pursued indigenously developed vaccines such as “ChulaCov19” with clinical trials commencing May 2021 as reported by Al Jazeera. Mahidol University commenced Phase 1 investigation into NDV-HXP-S by March 2021. Some have questioned this approach.


    For comparison, in the United States, the initiation of the PREP Act during the COVID-19 emergency effectively shields pharmaceutical producers to hospitals from any liability due to basic negligence. The government has a limited fund for injuries.


    Summary

    A total of 103 million COVID-19 doses have been administered to the Thai population, which totals about 70 million people. Those vaccines include AstraZeneca, Pfizer-BioNTech, Sinovac, and Janssen. To date, 8,470 claimants, out of a total of 11,707, have been compensated, reports the NHSO.


    Call to Action: TrialSite suggests once vaccines are approved and especially if mandates are initiated liability shields should be dropped for consumer protection


    Side effects cost govt B1bn
    Almost one billion baht in compensation has been paid out to Thais who suffered adverse side effects from the Covid-19 vaccine over the past eight months, says…
    www.bangkokpost.com

    It found that a single vaccine dose reduced the risk of needing hospital treatment by 52%. Adding the second dose increased the protection to 72%, although after 25 weeks that protection had faded to 52%.

    And two weeks after getting a third dose, that protection against hospitalisation was boosted to 88%.

    The UKHSA report said there was not enough data yet to work out how long this protection would last but it is expected to last longer than protection against developing symptoms.

    In people who already had symptoms, protection after each dose was slightly lower and reduced to 68% after a booster compared to unvaccinated people.


    Covid booster 88% effective against hospital treatment with Omicron
    UK health officials said the latest data reinforces the importance of getting a third dose.
    www.bbc.co.uk


    Report: https://www.medrxiv.org/conten…2.14.21267615v1.full-text

    Grossly Negligent to Ignore Vaccinated as UK Study Shows Fully Vaccinated Major Source of SARS-CoV-2 Community Transmission


    Grossly Negligent to Ignore Vaccinated as UK Study Shows Fully Vaccinated Major Source of SARS-CoV-2 Community Transmission
    A team of researchers based out of the United Kingdom (UK) recently studied a disappointing trend. The SARS-CoV-2 vaccines were supposed to stop or
    trialsitenews.com


    A team of researchers based out of the United Kingdom (UK) recently studied a disappointing trend. The SARS-CoV-2 vaccines were supposed to stop or seriously inhibit community transmission. In fact, many of the more draconian policies such as vaccine passports are all but premised on the concept that the vaccines stop transmission. As TrialSite follows results from study after study, it is evident the vaccines do not stop transmission, particularly since the onset of the far more infectious Delta variant of concern. But the latest variant, Omicron, is even more transmissible. Led by corresponding author Ajit Lalvani, with the National Institute of Health Research (NIHR) Health Protection Research Unit at the National Heart and Lung Institute, as well as the Imperial College London, and a team of colleagues investigated recent data evidencing the growing “epidemiological relevance” of those individuals fully vaccinated for COVID-19 in the UK. The study authors’ findings, published in the prestigious The Lancet, revealed that those individuals who are fully vaccinated also experience peak viral load comparable to unvaccinated cases. Moreover, the UK authors report that the fully vaccinated can be just as contagious as the unvaccinated which turns the assumptions upside down.


    Most recently in the UK, 39% (12 of 31) of breakthrough infections were due to fully vaccinated persons transmitting the disease to household contacts—that is, fully vaccinated epidemiologically linked index cases are proven to be a community transmission problem.


    Principia-Scientific referred to the recent study in The Lancet. They reported that in Germany as well, breakthrough infections since July 2021 have grown to nearly 17% of the total of patients aged 60 and up.


    The table below shows vaccination rates and the proportion of fully vaccinated people among symptomatic COVID-19 cases (age 60 and up) between July 21 and October 27, 2021, from the Robert Koch Institute.




    TrialSite has reported on the study of Gilbert Kampf in “Is Mass Vaccination Failing: One German Professor Raises this Concern.” The German professor shared his growing concern, “That the epidemiological relevance of COVID-19 vaccinated individuals is increasing,” as reported in the British Medical Journal (BMJ).


    The Data

    The UK team tapped into data from a UK community-based study called the Assessment of Transmission and Contagiousness of COVID-19 in Contacts (ATACCC). Here, they used ambulatory close contacts of confirmed SARS-CoV-2 cases who were involved with daily longitudinal URT sampling along with associated clinical and epidemiological data.


    The study team sought to quantify household transmission involving the delta variant while seeking to better understand how vaccination actually impacted household transmission of the variant—did vaccination dramatically reduce community transmission?


    What did they find?

    Tracking what they call “Secondary Attack Rate,” they discovered that those contacts exposed to the delta variant equaled the following:


    25% (95% CI 18–33) for fully vaccinated vs. 38% (24-53) in unvaccinated persons.

    The SAR impacting household contacts fully exposed to fully vaccinated cases was like household contacts exposed to unvaccinated index cases (25% [95% CI 15–35] for vaccinated vs 23% [15–31] for unvaccinated)

    12 (39%) of 31 infections in fully vaccinated household contacts originate from fully vaccinated epidemiologically linked index cases

    Peak viral load rises with age (difference of 0·39 [95% credible interval 0·03 to 0·79] in peak log10 viral load per mL between those aged 10 years and 50 years)

    Those fully vaccinated with delta variant infection were assessed with faster (posterior probability >0·84) mean rate of viral load decline (0·95 log10 copies per mL per day) as compared to unvaccinated people with pre-alpha (0.69), alpha (0.82) or delta (0.79) variant infections

    Faster viral load growth correlates to higher peak viral load (correlation 0·42 [95% credible interval 0·13 to 0·65]) and slower decline (–0·44 [–0·67 to –0·18])

    Conclusion

    The UK-based study team concluded that while vaccination does help mitigate delta variant risk, fully vaccinated persons “with breakthrough infections have peak viral load similar to unvaccinated cases, and can efficiently transmit infection in household settings, including to fully vaccinated contacts.”


    TrialSite has chronicled several studies now indicating material evidence for risk of viral transmission associated with fully vaccinated persons, especially in association with the Delta variant. Omicron is more transmissible than Delta based on a couple of study conclusions thus far, yet infections seen tend to be on the milder side. This, of course, could change with more widespread infection.


    Lead Research/Investigator

    Ajit Lalvani, Chair Infectious Diseases, Professor, NIHR Health Protection Research Unit, Respiratory Infections, National Health and Lung Institute, Imperial College London, Corresponding Author See the source for all the authors associated with ATACCC Study Investigators


    DEFINE_ME

    “Of the nearly 29,000 covid-linked fatalities in Texas during that period, more than 85 percent were of unvaccinated individuals. Nearly 7 percent of the deaths were among partially vaccinated people, while nearly 8 percent were fully vaccinated”.


    If this data is to believed, and it translates nationally, I would say it’s much better to be vaccinated than not,

    Even in the great state of Texas

    I have never myself expected vaccines to be perfect. Formulated againmst original COVID, they were worse against alpha, worse again against delta, and even more against omicron.


    This TSN diatribe sounds like a spoilt little boy who expected £1000 for a birthday present and complains when being given £100.



    A team of researchers based out of the United Kingdom (UK) recently studied a disappointing trend. The SARS-CoV-2 vaccines were supposed to stop or seriously inhibit community transmission.


    By whom? And no-one has even known whether they would even work at all against the next variant. We have now had 3 next variants!


    In fact, many of the more draconian policies such as vaccine passports are all but premised on the concept that the vaccines stop transmission.

    Actually, no. In France, for example, vaccine passports have driven up vaccination rates and therefore reduced hospitalisation and death. There has also been some decrease in yransmission due to vaccines, but it depends.


    Good news RobertBryant has posted data showing that even against omicron the original vaccines reduce household transmission by 50%. If replicated out of household, that is a reduction in R value to half of what it would otherwise be. That is as much as would be got from a significant lockdown...


    As TrialSite follows results from study after study, it is evident the vaccines do not stop transmission, particularly since the onset of the far more infectious Delta variant of concern. But the latest variant, Omicron, is even more transmissible.


    That was evident from very early on. But, medicine is not about absolutes. The vaccines do reduce transmission significantly. Although with very infectious variants reducing transmission just broadens a peak in time. That is what countries like the UK with stretched health services want, but I guess it is bad for many people who want things to finish as soon as possible and would prefer no reduction in transmission.


    Led by corresponding author Ajit Lalvani, with the National Institute of Health Research (NIHR) Health Protection Research Unit at the National Heart and Lung Institute, as well as the Imperial College London, and a team of colleagues investigated recent data evidencing the growing “epidemiological relevance” of those individuals fully vaccinated for COVID-19 in the UK. The study authors’ findings, published in the prestigious The Lancet, revealed that those individuals who are fully vaccinated also experience peak viral load comparable to unvaccinated cases. Moreover, the UK authors report that the fully vaccinated can be just as contagious as the unvaccinated which turns the assumptions upside down.


    Well, you clearly need recent boosters, But given those there seems a useful reduction. Unless you have unreasonable expectations and expect omicron not to still have R > 1 even with vaccination. Certainly in the UK we see the main role of vaccination as reducing hospitalisation and death. You would think that would be top priority for most people?


    THH

    79,000+ Australians Filing Compensation Claims for COVID-19 Vaccine Injuri


    79,000+ Australians Filing Compensation Claims for COVID-19 Vaccine Injuries
    Australia now is compensating COVID-19 vaccine patients or serious adverse events. Australian news reports that the COVID-19 vaccines have led to at least
    trialsitenews.com



    Australia now is compensating COVID-19 vaccine patients or serious adverse events. Australian news reports that the COVID-19 vaccines have led to at least 79,000 adverse reactions. For those claiming under $20,000 patients must provide evidence from their physician. For those with more serious conditions leading to claims over $20,000 require a review by a panel of legal experts. More nations are acknowledging that these vaccines can lead to injury and that those injured should be compensated.


    Australia has embraced a harder, more rigid approach to managing the pandemic including embracing some of the zero-tolerance COVID-19 approaches originating in China. By the summer Australia embraced an aggressive mass vaccination scheme as well. This has led to about 77% of the entire population vaccinated with 42.6 million doses administered as of December 30, 2021. Serious adverse events originating from COVID-19 vaccines are rare, but they do happen, and people need to be compensated for loss.


    Organized by Australia’s national government, the COVID-19 vaccines contributing to the adverse events include the following:


    Vaxzervia (AstraZeneca)

    Comirnaty (Pfizer)

    Spikevax (Moderna)

    The government, unlike others such as the U.S. federal government, acknowledges that vaccines can have side effects (adverse events). While they declare that most of these events will be mild and resolved in a few days some can be more severe.



    Recently Australia’s Channel 7 news had a series interviewing an induvial that had serious pericarditis due to an adverse reaction from the Pfizer vaccine. That video can be watched at the source below. This media introduced the CoVID-19 Vaccine Claim Scheme back in the summer.


    Who Monitors adverse events in Australia?

    The Therapeutic Goods Administration (TGA) closely monitor adverse events for suspected side effects, and often find they are not caused by the vaccine itself, but TrialSite suggests subtle or not so subtle pressure to find reasons not to connect the causation. TrialSite provides a link to the TGA COVID-19 vaccine safety monitoring and reporting activities or report a suspected side effect.


    More on Australia’s COVID-19 vaccine claims

    The Australian adverse event compensation program scheme overs the costs of injuries $1,000 and above due to administration of a TGA approved COVID-19 vaccine or due to an adverse event that is caused by a COVID-19 vaccination. The list of adverse effects for claims purposes under the scheme include the following clinical conditions that are diagnosed by a treating doctor and are included in the approved product information for the specific vaccine:


    anaphylactic reaction

    thrombosis with Thrombocytopenia Syndrome

    myocarditis

    pericarditis

    capillary leak syndrome

    demyelinating disorders including Guillain Barre Syndrome (GBS)

    Thrombocytopenia, including immune Thrombocytopenia, identified as a final diagnosis.

    According to the government website harm not covered by the scheme includes:


    COVID-19

    psychological and psychiatric conditions (e.g., shock)

    secondary injuries (e.g., injury suffered when fainting, or a haematoma at the injection site that becomes infected)

    the following other injuries unless they form part of the symptom complex of a clinical condition listed above: headache; fatigue; injection site reaction; muscle or joint pain; dizziness; diarrhea; pain in extremity; fever; insomnia; nausea; vomiting; lethargy; hyperhidrosis; chills; decreased appetite; malaise; lymphadenopathy; somnolence; abdominal pain; puritus; urticaria or rash; influenza-like illness; angioedema; anxiety-related reactions such as hyperventilation and fainting.

    Specified Administration Related Injuries which are clinically diagnosed will also be covered under the scheme.


    For claims between $1,000 and $20,000, claimants need to have been hospitalized for at least one night and provide applicable evidence of:


    the nature of the injury and medical documentation of its likely relationship to a COVID-19 vaccination

    hospitalization, due to a vaccine-related injury

    medical costs

    lost wages.

    The hospitalization requirement may be waived if outpatient treatment is received and the COVID-19 vaccine recipient was not admitted to hospital, when they otherwise would have been, because:


    of the nature of their clinical condition; or

    the recipient was in a rural or remote area making it difficult to access a hospital.

    The evidence requirements for claims $20,000 and over, including death, will shortly be advised as part of additional information to be published on the scheme in November 2021. Claims relating to a death will not require evidence of hospitalization.


    TrialSite recently reported on the Thailand’s COVID-19 vaccine compensation program. This media will continue to monitor various programs.


    https://www.health.gov.au/initiatives-and-programs/covid-19-vaccine-claims-scheme


    External Content youtu.be
    Content embedded from external sources will not be displayed without your consent.
    Through the activation of external content, you agree that personal data may be transferred to third party platforms. We have provided more information on this in our privacy policy.

    Quote from zorud

    Unvaccinated people were three times more likely to be reinfected than those who had their second vaccine 14 to 89 days ago.

    This is fake news based on paper tiger studies. You cannot use the PCR+ database for such studies as it is a fact that > 50% are false positive. You have to look e.g. at serious cases with a documented history. But here you run into the age issue.

    We have hard data from Israel hospitals, that show > 13x better protection (than from gene therapy) from an infection up to 40 x in the full population (includes more younger).

    99.9% of all US CoV-19 publications are fabricated data. Pfizer spends billions. See Andrew Hill or Yale school of medicine....

    Quote from THHuxleynew

    Good news RobertBryant has posted data showing that even against omicron the original vaccines reduce household transmission by 50%. If replicated out of household, that is a reduction in R value to half of what it would otherwise be. That is as much as would be got from a significant lockdown...

    Repeating fake news does not make them better, It's a paper tiger study. Vaccinated do far less testing so this chain is heavily under reported in databases.

    As you know from UK data. "Vaccinated only" spread up to 5x more often!! The trick is that almost all recovered end up in the vaccinated cohort. So every time you read such a paper tiger study you can divide all vaccine arm values by at least 2 or multiply the infection rate by 2x. Recovered are sterile vaccinated not!!!

    Quote from Fm1

    Australia now is compensating COVID-19 vaccine patients or serious adverse events. Australian news reports that the COVID-19 vaccines have led to at least 79,000 adverse reactions.

    The best of the best "vaccines" did produce about 80'000 serious medical reactions! But Australia had only 2200 deaths among 25 million. So the "vaccine" damage rate for the population is about 0.3% and and damage:death rate is about 40.... But only 1300 death happened during the vaccine phase...


    What does this prove?? The true damage rate is at least 10x larger than we find in the EU/VAERS database.


    All this damage for a 50% better survival rate of the people older than 70??????? You could have had this for 1$ with early treatment...and no damage...

Subscribe to our newsletter

It's sent once a month, you can unsubscribe at anytime!

View archive of previous newsletters

* indicates required

Your email address will be used to send you email newsletters only. See our Privacy Policy for more information.

Our Partners

Supporting researchers for over 20 years
Want to Advertise or Sponsor LENR Forum?
CLICK HERE to contact us.